Synairgen Presents In Vitro Potency Data for Interferon Beta Against SARS-CoV-2 Variants and Lung Antiviral Biomarker Data for Inhaled SNG001 at the 8th ESWI Influenza Conference

Author's Avatar
Dec 07, 2021

- In vitro data demonstrate antiviral activity of SNG001 against multiple variants of SARS-CoV-2

- Clinical biomarker data show inhaled SNG001 stimulates lung antiviral responses

PR Newswire